← Back to Search

eDECIDE Web-based Intervention Group for Type 2 Diabetes (eDECIDE Trial)

N/A

Recruiting

Led By Michelle L Redmond, PhD

Research Sponsored by University of Kansas Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosis of Type 2 Diabetes per one of the following

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 15 weeks

Awards & highlights

eDECIDE Trial Summary

This trial will help determine if the DECIDE program is an effective way to manage diabetes.

Who is the study for?

This trial is for African American individuals who speak English, have daily internet access, can read at a 5th-grade level or higher, and have been diagnosed with Type 2 Diabetes based on specific blood sugar levels or HbA1c percentage.Check my eligibility

What is being tested?

The study is testing the eDECIDE web-based intervention against the traditional face-to-face DECIDE curriculum. It aims to see if managing diabetes through an online program is as effective as in-person education.See study design

What are the potential side effects?

Since this trial involves educational interventions rather than medications, there are no direct medical side effects. However, participants may experience stress or frustration related to technology use.

eDECIDE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with Type 2 Diabetes.

eDECIDE Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 15 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~15 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 15 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Task Analysis Wireframe Development part 1

Task Analysis Wireframe Development part 2

Task Analysis study process chart

eDECIDE Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: eDECIDE Web-based Intervention GroupExperimental Treatment1 Intervention

Participants randomized to the eDECIDE arm will use the online version of the program through the eDECIDE study portal. Participants in this group will receive bi-weekly calls from their health coach to mark their progress with the program.

Group II: DECDIE Traditional GroupActive Control1 Intervention

Participants randomized to the DECIDE group will receive a copy of the curriculum via mail and will be a self-study group where they go through the curriculum on their own with 4 calls from their health coach.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Heart, Lung, and Blood Institute (NHLBI)NIH

3,838 Previous Clinical Trials

47,851,614 Total Patients Enrolled

Wichita State UniversityUNKNOWN

3 Previous Clinical Trials

384 Total Patients Enrolled

University of Kansas Medical CenterLead Sponsor

463 Previous Clinical Trials

169,230 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research project accept participants over the age of fifty?

"According to the inclusion criteria, this medical study is open for patients between 16 and 65 years old. Additionally, there are 192 trials available for minors and 1067 clinical studies that seniors can take part in."

Answered by AI

Are any openings available for individuals to join this experiment?

"According to the latest data on clinicaltrials.gov, this specific trial is no longer accepting applicants. The posting was first made on June 5th 2019 and edited as recently as December 14th 2021. However, there are 1,392 other active studies searching for participants right now."

Answered by AI

Who is eligible to join this clinical trial?

"This clinical trial is aiming to recruit 11 individuals aged 16-65 with a diagnosis of type 2 diabetes mellitus, who are African American, English speaking, have regular access the Internet, and possess at least a 5th grade reading level. Additionally, participants must pass one or more of these tests: fasting blood glucose ≥ 126 mg/dL; 2 hr plasma glucose ≥ 200 mg/dL; glycosylated hemoglobin HbA1c ≥ 6.5%; random plasma glucose ≥200 mg/dL.."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Task Analysis Study of DECIDE For African American Patients With Type 2 Diabetes

Michelle Redmond 2019. "A Task Analysis Study of DECIDE For African American Patients With Type 2 Diabetes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03855449.

All > Diabetes Type 2 > Type 2 Diabetes